查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828092

2025年全球自動輸血設備市場報告

Autotransfusion Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，自動輸血設備的市場規模穩定成長，預計2024年將達到12.1億美元，2025年將達到12.6億美元，複合年成長率為4.4%。預測期內的成長可歸因於多種因素，例如外科手術的增加、心血管疾病、整形外科手術和關節關節重建手術的日益流行、對患者安全的日益重視以及降低輸血成本的努力。

預計未來幾年自動輸血設備市場規模將強勁成長，2029年將達到16.7億美元，複合年成長率為7.2%。預測期內的成長歸因於老年人口的成長、門診手術中心的擴張、產科對血液保護的重視以及新興醫療保健市場的普及。預測期內的主要趨勢包括血液處理技術的進步、先進感測器的整合、各種手術的客製化、單一供體閉合迴路系統以及設備小型化。

自體輸血裝置是一種用於在醫療操作過程中抽取並重新輸注患者自身血液的工具，該過程稱為自體輸血。這種方法顯著減少了對異體輸血的需求。這類裝置廣泛應用於急診和外科創傷護理。

自動輸血設備的關鍵組件包括自體輸血系統、耗材和配件。自體輸血系統涵蓋醫療設備和方法，使患者能夠接收自身血液進行輸血，無需外部供血。它們用於各種醫療應用，包括心血管、整形外科、神經科、產科和婦科手術，並滿足各種最終用戶的需求，包括醫院、專科診所和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供自動輸血設備光學元件市場統計數據，包括全球市場規模、區域佔有率、競爭對手的自動輸血設備光學元件市場佔有率、詳細的自動輸血設備光學元件細分市場、市場趨勢和機遇，以及在自動輸血設備光學元件行業取得成功所需的數據。本自動輸血設備光學元件市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年7.2%的預測成長率，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，例如對英國血液回收過濾器和以色列離心機轉鼓系統的進口限制，從而增加術中血液回收的成本。此外，由於貿易緊張局勢和限制加劇，互惠關稅以及全球經濟和貿易的負面影響也將對美國產生更廣泛的影響。

心血管疾病 (CVD) 的預期成長將推動自體輸血設備市場的成長。 CVD 會損害心臟和血管，在減少對異體輸血的依賴方面發揮關鍵作用。這些設備有助於患者重新輸入自身血液，從而降低與捐贈者輸血相關的風險。值得注意的是，美國心臟協會 ( 美國 Heart Association) 的《心臟病和中風統計數據 - 2022 年更新》報告強調，CVD 是全球主要死亡原因，每年約奪走 1790 萬人的生命，這突顯了市場的發展軌跡。

日益成長的血液保護需求預計將成為自體輸血設備市場的主要驅動力。在外科手術中，血液保護旨在避免術中和術後異體輸血，從而改善患者預後並保護患者健康。自體輸血設備可有效減少外科手術的出血，有助於改善病患復健。根據世界衛生組織 (WHO) 2023 年 6 月發布的報告，73% 的報告國家（171 個國家中的 125 個）已實施國家血液政策。這表明血液保護措施已被廣泛採用，並證實了市場的成長。

預計整形外科手術的興起將推動自體輸血設備市場的成長。整形外科手術包括解決與肌肉骨骼系統相關問題的醫療程序，包括骨骼、關節、韌帶、肌腱和肌肉。此類手術的增加與治療損傷和退化性疾病的需求不斷成長以及老齡化人口需要關節置換和修復有關。自體輸血設備在整形外科手術中發揮著至關重要的作用，它透過收集、處理和回輸患者在手術中流失的血液，減少了對捐血的需求，並最大限度地降低了輸血相關併發症的風險。例如，根據英國整形外科協會的一份報告，2022 年 5 月，英格蘭 3 月進行了超過 42,000 例整形外科手術，這是自 2021 年 6 月以來的最高數字。因此，整形外科手術頻率的增加正在推動自體輸血設備的需求。

自動輸血設備市場的主要企業致力於打造技術先進的解決方案，包括旨在提高輸血準確性、效率和患者預後的下一代智慧控制軟體。這款新一代軟體利用複雜的演算法即時最佳化血液採集、處理和回輸，進而提高效率和病人安全性。例如，2023年3月，美國血液和血漿供應及服務公司Haemonetics Corporation宣布，其Cell Saver Elite+自體輸血系統已獲得美國食品藥物管理局（FDA）的批准。這款新一代軟體可在預計會出現中度至重度失血的外科手術過程中最大限度地提高紅血球的回收率。這項創新升級簡化了自體輸血流程，最大限度地減少了不必要的異體輸血，並最終改善了患者的預後。

產品開發創新，尤其是下一代智慧控制軟體的整合，已被證明是領先的自動輸血設備製造商關注的重點。此次名為「智慧控制」的軟體升級引入了多項重大改進，旨在簡化操作，從而提升效率和用戶體驗。例如，2023年3月，美國醫療保健公司Haemonetics的下一代智慧控制軟體獲得了FDA 510(k)批准，該軟體專為其Cell Saver Elite+自動輸血系統設計。這項軟體技術的進步再次印證了Haemonetics致力於開發開創性解決方案的承諾，旨在改善涉及中度至重度失血情況的手術中的患者預後，涵蓋心臟、整形外科、創傷、移植、血管和婦科手術。

自動輸血設備市場的主要企業包括 Becton Dickinson and Company、Medtronic plc、LivaNova plc、Haemonetics Corporation、Fresenius SE & Co KGaA、Terumo Corporation、Asahi Kasei Medical Co.Ltd.、B. Braun Melsungen AG、GE HealthCare Technologies Inc.、Ceei Medical Co.Ltd.. AB、北京中科思凱科技有限公司、Braille Biomedica、Redax SpA、Teleflex Incorporated、Zimmer Biomet Holdings Inc.、Gen World Medical Devices Corporation、Soma Technology International LLC、北京晶晶醫療器材有限公司、強生公司、Sorin Group、百特國際公司、Dideco 和 Nipro Corporation。

2024年自動輸血設備市場最大的地區是北美。預計預測期內，亞太地區將成為全球自動輸血設備市場成長最快的地區。自動輸血設備市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

自動輸血設備市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

自動輸血設備市場包括體外循環輸液設備和非體外循環輸液設備的銷售。該市場的價值指的是“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球自動輸血設備：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球自動輸血設備市場：成長率分析
  • 全球自動輸血設備市場表現：規模與成長，2019-2024
  • 全球自動輸血設備市場預測：規模與成長，2024-2029年，2034年
  • 全球自動輸血設備：總目標市場（TAM）

第6章 市場細分

  • 全球自動輸血設備市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 自體輸血系統
  • 耗材及配件
  • 全球自動輸血設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 心血管外科
  • 整形外科手術
  • 神經外科
  • 婦科手術
  • 其他
  • 全球自動輸血設備市場最終用途、效能及預測（2019-2024、2024-2029、2034）
  • 專科診所
  • 其他
  • 全球自體輸血設備市場：自體輸血系統細分、類型、效能與預測（2019-2024 年、2024-2029 年、2034 年）
  • 手術自體輸血系統
  • 緊急自體輸血系統
  • 常規流量自體輸血系統
  • 全球自動輸血設備市場：耗材及配件細分、按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 恢復儲層
  • 血液過濾器
  • 管組
  • 泵浦
  • 抗凝血劑

第7章 區域和國家分析

  • 全球自動輸血設備市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球自動輸血設備市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 自動輸血設備市場：競爭格局
  • 自動輸血設備市場：公司簡介
    • Becton Dickinson And Company
    • Medtronic plc
    • LivaNova plc
    • Haemonetics Corporation
    • Fresenius SE & Co KGaA

第31章：其他領先和創新企業

  • Terumo Corporation
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • GE HealthCare Technologies Inc.
  • Cerus Corporation
  • Stryker Corporation
  • Atrium Medical Technologies
  • Brightwake Ltd.
  • Getinge AB
  • Beijing ZKSK Technology Co. Ltd.
  • Braile Biomedica
  • Redax SpA
  • Teleflex Incorporated
  • Zimmer Biomet Holdings Inc.
  • Gen World Medical Devices Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年自動輸血設備市場：提供新機會的國家
  • 2029年自動輸血設備市場：細分市場將帶來新機會
  • 2029年自動輸血設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23948u

Autotransfusion devices are tools utilized to collect and reintroduce a patient's own blood during medical procedures, reducing reliance on donated blood-a method known as autologous blood transfusion. This approach notably diminishes the necessity for allogeneic (from a separate donor) blood transfusions. These devices find widespread application in trauma care within emergency departments and surgical settings.

The primary components of autotransfusion devices encompass autotransfusion systems, consumables, and accompanying accessories. Autotransfusion systems encompass both medical devices and methodologies enabling patients to receive their own blood for transfusions, negating the need for external donor blood. They serve diverse medical applications such as cardiovascular, orthopedic, neurological, obstetrics, gynecology surgeries, among others, and cater to various end-users including hospitals, specialized clinics, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The autotransfusion devices market research report is one of a series of new reports from The Business Research Company that provides autotransfusion devices optical components market statistics, including autotransfusion devices optical components industry global market size, regional shares, competitors with a autotransfusion devices optical components market share, detailed autotransfusion devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the autotransfusion devices optical components industry. This autotransfusion devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autotransfusion devices market size has grown steadily in recent years. It will grow from $1.21 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to an increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, and efforts to reduce blood transfusion costs.

The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, and adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, and miniaturization of devices.

The forecast of 7.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restricted imports of blood salvage filters from the UK and centrifugal bowl systems from Israel, increasing costs for intraoperative blood recovery.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cardiovascular diseases (CVDs) is set to propel growth within the autotransfusion device market. CVDs encompass a spectrum of heart and blood vessel disorders, and autotransfusion devices play a crucial role in reducing reliance on allogeneic blood transfusions. These devices facilitate reinfusion of a patient's own blood, mitigating the risks associated with donor blood transfusions. Notably, the American Heart Association's Heart Disease and Stroke Statistics-2022 Update report highlighted CVDs as the foremost global cause of mortality, claiming approximately 17.9 million lives annually, underscoring the market's trajectory.

The escalating demand for blood conservation is expected to be a significant driver for the autotransfusion devices market. Within surgical contexts, blood conservation aims to avoid allogeneic blood transfusions during and post-surgery to enhance patient outcomes and safeguard their well-being. Autotransfusion devices effectively minimize blood loss during surgical procedures, contributing to improved patient recovery. As per the June 2023 report by the World Health Organization, a substantial percentage of reporting countries, accounting for 73% or 125 out of 171, have implemented national blood policies. This indicates a widespread initiative toward blood conservation, affirming the market's growth.

The rising number of orthopedic surgeries is anticipated to fuel the growth of the autotransfusion devices market. Orthopedic surgeries involve medical procedures that address issues related to the musculoskeletal system, which includes bones, joints, ligaments, tendons, and muscles. The increase in these surgeries can be linked to a growing demand for treatments for injuries and degenerative conditions, as well as an aging population that requires joint replacements and repairs. Autotransfusion devices play a crucial role in orthopedic surgeries by collecting, processing, and reinfusing a patient's blood lost during the operation, thereby reducing the need for donor blood and minimizing the risk of transfusion-related complications. For example, the British Orthopaedic Association reported that in May 2022, England experienced over 42,000 orthopedic surgeries in March 2022, marking the highest number since June 2021. Consequently, the rising frequency of orthopedic surgeries is driving demand for autotransfusion devices.

Leading companies in the autotransfusion devices market are concentrating on creating technologically advanced solutions, including next-generation intelligent control software designed to improve precision, efficiency, and patient outcomes during blood transfusions. This next-generation software utilizes sophisticated algorithms to optimize the recovery, processing, and reinfusion of blood in real time, thereby enhancing both efficiency and patient safety. For example, in March 2023, Haemonetics Corporation, a U.S.-based provider of blood and plasma supplies and services, announced that the Cell Saver Elite+ Autotransfusion System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation software maximizes the recovery of red blood cells during surgical procedures where medium to high blood loss is anticipated. This innovative upgrade streamlines autotransfusion processes, minimizes unnecessary allogeneic transfusions, and ultimately leads to improved patient outcomes.

Innovations in product development, particularly the integration of next-generation intelligent control software, signify a pivotal focus among major autotransfusion device companies. This software upgrade, known as Intelligent Control, introduces significant enhancements aimed at simplifying operations, thereby enhancing efficiency and user experience. For instance, Haemonetics, a US-based healthcare company, received FDA 510(k) clearance for its next-generation Intelligent Control software in March 2023, specifically designed for the Cell Saver Elite+ autotransfusion system. This advancement in software technology reaffirms Haemonetics' commitment to pioneering solutions for improved patient outcomes in surgeries involving medium to high blood loss scenarios, spanning cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries.

Major companies operating in the autotransfusion devices market include Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomedica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation

North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autotransfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The autotransfusion devices market consists of sales of on-pump transfusion devices and off-pump transfusion devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autotransfusion Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autotransfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autotransfusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autotransfusion devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Autotransfusion Systems; Consumables And Accessories
  • 2) By Application: Cardiovascular Surgeries; Orthopedic Surgeries; Neurological Surgeries; Obstetrics And Gynecology Surgeries; Other Applications
  • 3) By End-Use: Hospitals; Specialty Clinics; Other End Users
  • Subsegments:
  • 1) By Autotransfusion Systems: Surgical Autotransfusion Systems; Emergency Autotransfusion Systems; Continuous Flow Autotransfusion Systems
  • 2) By Consumables And Accessories: Collection Reservoirs; Blood Filters; Tubing Sets; Pumps; Anticoagulants
  • Companies Mentioned: Becton Dickinson And Company; Medtronic plc; LivaNova plc; Haemonetics Corporation; Fresenius SE & Co KGaA; Terumo Corporation; Asahi Kasei Medical Co. Ltd.; B. Braun Melsungen AG; GE HealthCare Technologies Inc.; Cerus Corporation; Stryker Corporation; Atrium Medical Technologies; Brightwake Ltd.; Getinge AB; Beijing ZKSK Technology Co. Ltd.; Braile Biomedica; Redax S.p.A.; Teleflex Incorporated; Zimmer Biomet Holdings Inc.; Gen World Medical Devices Corporation; Soma Technology International LLC; Beijing Jingjing Medical Equipment Co. Ltd.; Johnson & Johnson Inc.; Sorin Group; Baxter International Inc.; Dideco; Nipro Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autotransfusion Devices Market Characteristics

3. Autotransfusion Devices Market Trends And Strategies

4. Autotransfusion Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autotransfusion Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Autotransfusion Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Autotransfusion Devices Market Growth Rate Analysis
  • 5.4. Global Autotransfusion Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Autotransfusion Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Autotransfusion Devices Total Addressable Market (TAM)

6. Autotransfusion Devices Market Segmentation

  • 6.1. Global Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autotransfusion Systems
  • Consumables And Accessories
  • 6.2. Global Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Obstetrics And Gynecology Surgeries
  • Other Applications
  • 6.3. Global Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Specialty Clinics
  • Other End Users
  • 6.4. Global Autotransfusion Devices Market, Sub-Segmentation Of Autotransfusion Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Autotransfusion Systems
  • Emergency Autotransfusion Systems
  • Continuous Flow Autotransfusion Systems
  • 6.5. Global Autotransfusion Devices Market, Sub-Segmentation Of Consumables And Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Collection Reservoirs
  • Blood Filters
  • Tubing Sets
  • Pumps
  • Anticoagulants

7. Autotransfusion Devices Market Regional And Country Analysis

  • 7.1. Global Autotransfusion Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Autotransfusion Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autotransfusion Devices Market

  • 8.1. Asia-Pacific Autotransfusion Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autotransfusion Devices Market

  • 9.1. China Autotransfusion Devices Market Overview
  • 9.2. China Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autotransfusion Devices Market

  • 10.1. India Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autotransfusion Devices Market

  • 11.1. Japan Autotransfusion Devices Market Overview
  • 11.2. Japan Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autotransfusion Devices Market

  • 12.1. Australia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autotransfusion Devices Market

  • 13.1. Indonesia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autotransfusion Devices Market

  • 14.1. South Korea Autotransfusion Devices Market Overview
  • 14.2. South Korea Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autotransfusion Devices Market

  • 15.1. Western Europe Autotransfusion Devices Market Overview
  • 15.2. Western Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autotransfusion Devices Market

  • 16.1. UK Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autotransfusion Devices Market

  • 17.1. Germany Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autotransfusion Devices Market

  • 18.1. France Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autotransfusion Devices Market

  • 19.1. Italy Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autotransfusion Devices Market

  • 20.1. Spain Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autotransfusion Devices Market

  • 21.1. Eastern Europe Autotransfusion Devices Market Overview
  • 21.2. Eastern Europe Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autotransfusion Devices Market

  • 22.1. Russia Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autotransfusion Devices Market

  • 23.1. North America Autotransfusion Devices Market Overview
  • 23.2. North America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autotransfusion Devices Market

  • 24.1. USA Autotransfusion Devices Market Overview
  • 24.2. USA Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autotransfusion Devices Market

  • 25.1. Canada Autotransfusion Devices Market Overview
  • 25.2. Canada Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autotransfusion Devices Market

  • 26.1. South America Autotransfusion Devices Market Overview
  • 26.2. South America Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autotransfusion Devices Market

  • 27.1. Brazil Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autotransfusion Devices Market

  • 28.1. Middle East Autotransfusion Devices Market Overview
  • 28.2. Middle East Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autotransfusion Devices Market

  • 29.1. Africa Autotransfusion Devices Market Overview
  • 29.2. Africa Autotransfusion Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Autotransfusion Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Autotransfusion Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autotransfusion Devices Market Competitive Landscape And Company Profiles

  • 30.1. Autotransfusion Devices Market Competitive Landscape
  • 30.2. Autotransfusion Devices Market Company Profiles
    • 30.2.1. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. LivaNova plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fresenius SE & Co KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Autotransfusion Devices Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Asahi Kasei Medical Co. Ltd.
  • 31.3. B. Braun Melsungen AG
  • 31.4. GE HealthCare Technologies Inc.
  • 31.5. Cerus Corporation
  • 31.6. Stryker Corporation
  • 31.7. Atrium Medical Technologies
  • 31.8. Brightwake Ltd.
  • 31.9. Getinge AB
  • 31.10. Beijing ZKSK Technology Co. Ltd.
  • 31.11. Braile Biomedica
  • 31.12. Redax S.p.A.
  • 31.13. Teleflex Incorporated
  • 31.14. Zimmer Biomet Holdings Inc.
  • 31.15. Gen World Medical Devices Corporation

32. Global Autotransfusion Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autotransfusion Devices Market

34. Recent Developments In The Autotransfusion Devices Market

35. Autotransfusion Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Autotransfusion Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Autotransfusion Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Autotransfusion Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer